Orbis exits: East Coast pharmaceutical firm acquires Lenexa biotech company

Injecting a Kansas startup into its global efforts will help New Jersey-based Adare Pharmaceuticals boost its core business and strengthen in-roads into animal health and over-the-counter (OTC) markets, the companies said Monday. Orbis Biosciences’ acquisition was finalized Thursday for an undisclosed amount. The startup — which focuses on licensing its technology to companies to optimize their…

Read More